Variant report

Variant	nsv978371
Chromosome Location	chr17:15726145-15735621
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr17:15732174-15732334	K562	blood:	n/a	n/a
2	ARID3A	chr17:15732156-15732356	HepG2	liver:	n/a	n/a
3	ATF2	chr17:15734474-15734908	GM12878	blood:	n/a	n/a
4	ATF2	chr17:15734368-15734979	GM12878	blood:	n/a	n/a
5	BATF	chr17:15733144-15733411	GM12878	blood:	n/a	n/a
6	BATF	chr17:15734384-15735036	GM12878	blood:	n/a	chr17:15734678-15734689
7	BATF	chr17:15734490-15734882	GM12878	blood:	n/a	chr17:15734678-15734689
8	BATF	chr17:15732098-15732321	GM12878	blood:	n/a	n/a
9	BCL11A	chr17:15734498-15734876	GM12878	blood:	n/a	n/a
10	BCL11A	chr17:15734440-15735027	GM12878	blood:	n/a	n/a
11	BCL3	chr17:15734503-15734817	GM12878	blood:	n/a	n/a
12	BCL3	chr17:15734482-15734794	GM12878	blood:	n/a	n/a
13	BCLAF1	chr17:15734359-15734936	GM12878	blood:	n/a	n/a
14	BCLAF1	chr17:15734478-15734901	GM12878	blood:	n/a	n/a
15	BHLHE40	chr17:15734481-15734938	GM12878	blood:	n/a	n/a
16	CEBPB	chr17:15734577-15734819	GM12878	blood:	n/a	n/a
17	CEBPB	chr17:15734346-15735099	GM12878	blood:	n/a	n/a
18	CEBPB	chr17:15732160-15732382	Hela-S3	cervix:	n/a	n/a
19	CHD2	chr17:15734481-15734789	GM12878	blood:	n/a	n/a
20	CTCF	chr17:15732065-15732413	K562	blood:	n/a	chr17:15732214-15732230 chr17:15732213-15732231 chr17:15732216-15732229
21	CTCF	chr17:15732180-15732330	HEEpiC	esophagus:	n/a	chr17:15732214-15732230 chr17:15732213-15732231 chr17:15732216-15732229
22	CTCF	chr17:15732080-15732230	GM12864	blood:	n/a	chr17:15732214-15732230 chr17:15732216-15732229
23	CTCF	chr17:15732080-15732230	AG10803	skin:	n/a	chr17:15732214-15732230 chr17:15732216-15732229
24	CTCF	chr17:15732133-15732388	T-47D	breast:	n/a	chr17:15732214-15732230 chr17:15732213-15732231 chr17:15732216-15732229
25	CTCF	chr17:15732160-15732310	HEEpiC	esophagus:	n/a	chr17:15732214-15732230 chr17:15732213-15732231 chr17:15732216-15732229
26	CTCF	chr17:15732180-15732330	WERI-Rb-1	eye:	n/a	chr17:15732214-15732230 chr17:15732213-15732231 chr17:15732216-15732229
27	CTCF	chr17:15732120-15732270	HCT-116	colon:	n/a	chr17:15732214-15732230 chr17:15732213-15732231 chr17:15732216-15732229
28	CTCF	chr17:15732100-15732250	GM12869	blood:	n/a	chr17:15732214-15732230 chr17:15732213-15732231 chr17:15732216-15732229
29	CTCF	chr17:15732120-15732270	HRPEpiC	eye:	n/a	chr17:15732214-15732230 chr17:15732213-15732231 chr17:15732216-15732229
30	CTCF	chr17:15732080-15732230	GM12878	blood:	n/a	chr17:15732214-15732230 chr17:15732216-15732229
31	CTCF	chr17:15732087-15732394	GM12891	blood:	n/a	chr17:15732214-15732230 chr17:15732213-15732231 chr17:15732216-15732229
32	CTCF	chr17:15732086-15732433	MCF-7	breast:	n/a	chr17:15732214-15732230 chr17:15732213-15732231 chr17:15732216-15732229
33	CTCF	chr17:15732103-15732414	MCF-7	breast:	n/a	chr17:15732214-15732230 chr17:15732213-15732231 chr17:15732216-15732229
34	CTCF	chr17:15732520-15732670	WI-38	lung:	n/a	n/a
35	CTCF	chr17:15732200-15732350	WERI-Rb-1	eye:	n/a	chr17:15732214-15732230 chr17:15732213-15732231 chr17:15732216-15732229
36	CTCF	chr17:15732120-15732270	GM12872	blood:	n/a	chr17:15732214-15732230 chr17:15732213-15732231 chr17:15732216-15732229
37	CTCF	chr17:15732096-15732376	GM19240	blood:	n/a	chr17:15732214-15732230 chr17:15732213-15732231 chr17:15732216-15732229
38	CTCF	chr17:15732091-15732376	GM13977	blood:	n/a	chr17:15732214-15732230 chr17:15732213-15732231 chr17:15732216-15732229
39	CTCF	chr17:15732064-15732408	HUVEC	blood vessel:	n/a	chr17:15732214-15732230 chr17:15732213-15732231 chr17:15732216-15732229
40	CTCF	chr17:15732015-15732415	IMR90	lung:	n/a	chr17:15732214-15732230 chr17:15732213-15732231 chr17:15732216-15732229
41	CTCF	chr17:15732500-15732650	AG10803	skin:	n/a	n/a
42	CTCF	chr17:15732160-15732310	GM06990	blood:	n/a	chr17:15732214-15732230 chr17:15732213-15732231 chr17:15732216-15732229
43	CTCF	chr17:15731993-15732432	A549	lung:	n/a	chr17:15732214-15732230 chr17:15732213-15732231 chr17:15732216-15732229
44	CTCF	chr17:15732180-15732330	HBMEC	blood vessel:	n/a	chr17:15732214-15732230 chr17:15732213-15732231 chr17:15732216-15732229
45	CTCF	chr17:15732080-15732230	HepG2	liver:	n/a	chr17:15732214-15732230 chr17:15732216-15732229
46	CTCF	chr17:15732088-15732406	MCF-7	breast:	n/a	chr17:15732214-15732230 chr17:15732213-15732231 chr17:15732216-15732229
47	CTCF	chr17:15732420-15732570	HCM	heart:	n/a	n/a
48	CTCF	chr17:15732088-15732440	A549	lung:	n/a	chr17:15732214-15732230 chr17:15732213-15732231 chr17:15732216-15732229
49	CTCF	chr17:15732500-15732650	AG09319	gingival:	n/a	n/a
50	CTCF	chr17:15732180-15732330	SK-N-SH_RA	brain:	n/a	chr17:15732214-15732230 chr17:15732213-15732231 chr17:15732216-15732229

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr17:15731737..15732560-chr17:15901825..15902694,3	MCF-7	breast:
2	chr17:15732168..15733133-chr17:15847994..15848750,2	MCF-7	breast:

Variant related genes	Relation type
ENSG00000227790	TF binding region
ENSG00000170425	chromatin interactions

Extended variants
information (count: 175 )
Associated
traits (count: 128 )

Variant overlapped rSNPs/rCNVs (count:175 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs550392426	chr17:15726148-15726149	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs570050836	chr17:15726150-15726151	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs562644629	chr17:15726232-15726233	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs538778919	chr17:15726243-15726244	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs552137111	chr17:15726271-15726272	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs375393928	chr17:15726285-15726286	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs7217399	chr17:15726303-15726304	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs553655235	chr17:15726347-15726348	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs573738178	chr17:15726378-15726379	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs138748096	chr17:15727838-15727839	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs188167831	chr17:15727869-15727870	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs570515321	chr17:15727875-15727876	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs559410554	chr17:15727888-15727889	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs149402961	chr17:15731812-15731813	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs534255441	chr17:15731836-15731837	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs191513222	chr17:15731844-15731845	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs397832286	chr17:15731906-15731907	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs481648	chr17:15731923-15731924	Inactive region	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
19	rs536241915	chr17:15731943-15731944	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs397832285	chr17:15731954-15731955	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs556566399	chr17:15731961-15731962	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs529479041	chr17:15731975-15731976	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs558169214	chr17:15731980-15731981	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs537765614	chr17:15732012-15732013	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs183943579	chr17:15732021-15732022	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs577419701	chr17:15732055-15732056	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs540283305	chr17:15732105-15732106	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs188718505	chr17:15732140-15732141	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs180756292	chr17:15732183-15732184	Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs542239253	chr17:15732256-15732257	Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs562504250	chr17:15732308-15732309	Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs532006654	chr17:15732320-15732321	Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs4054234	chr17:15732334-15732335	Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs3843042	chr17:15732344-15732345	Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs552123564	chr17:15732348-15732349	Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs565429116	chr17:15732365-15732366	Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs143952506	chr17:15732408-15732409	Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs186081752	chr17:15732412-15732413	Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs567650613	chr17:15732473-15732474	Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs148209194	chr17:15732483-15732484	Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs573160493	chr17:15732499-15732500	Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs397843490	chr17:15732516-15732517	Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs549890986	chr17:15732528-15732529	Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs397832848	chr17:15732529-15732530	Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs141157748	chr17:15732542-15732543	Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs566263534	chr17:15732565-15732566	Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs1810410	chr17:15732567-15732568	Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs397833181	chr17:15732588-15732589	Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs397833182	chr17:15732598-15732599	Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs577556794	chr17:15732631-15732632	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:128)

Disease	PMID	Source
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	17603634	CNVD
Melanoma	18172304	CNVD
Glioblastoma multiforme	19435819	CNVD
Non-small cell lung cancer	19010865	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16774939	CNVD
Hepatocellular carcinoma	18803288	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Acute myeloid leukemia	17237825	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Multiple myeloma	16616336	CNVD
Multiple myeloma	17550852	CNVD
Pancreatic cancer	21811587	CNVD
Autism	17322880	CNVD
Hereditary neuropathy with liability to pressure palsy	19521722	CNVD
Schizophrenia	19571808	CNVD
Schizophrenia	19955444	CNVD
Charcot-marie-tooth disease	18787571	CNVD
Breast cancer	20409316	CNVD
Autism	18414403	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Myelofibrosis	22110671	CNVD
Peripheral neuropathy	21193943	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	22958593	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Ovarian cancer	20844748	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
ovarian endometriomas	16273235	CNVD
Breast cancer	21858162	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17142309	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Autism	22102821	CNVD
Gastric cancer	18160780	CNVD
Non-syndromic sensorineural hearing loss	19212409	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:63 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:15726000-15726400	Enhancers	Liver	Liver
2	chr17:15732000-15732400	Enhancers	Duodenum Mucosa	Duodenum
3	chr17:15732200-15732600	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
4	chr17:15732400-15732600	Flanking Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
5	chr17:15732400-15732600	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
6	chr17:15732400-15732600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
7	chr17:15732400-15732600	Enhancers	Primary hematopoietic stem cells short term culture	blood
8	chr17:15732400-15732600	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
9	chr17:15732400-15732600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
10	chr17:15732400-15732600	Flanking Active TSS	Muscle Satellite Cultured Cells	--
11	chr17:15732400-15732600	Enhancers	Adipose Nuclei	Adipose
12	chr17:15732400-15732600	Enhancers	Liver	Liver
13	chr17:15732400-15732600	Enhancers	Brain Anterior Caudate	brain
14	chr17:15732400-15732600	Enhancers	Brain Cingulate Gyrus	brain
15	chr17:15732400-15732600	Enhancers	Brain Germinal Matrix	brain
16	chr17:15732400-15732600	Enhancers	Colon Smooth Muscle	Colon
17	chr17:15732400-15732600	Enhancers	Duodenum Smooth Muscle	Duodenum
18	chr17:15732400-15732600	Enhancers	Fetal Intestine Small	intestine
19	chr17:15732400-15732600	Enhancers	Fetal Kidney	kidney
20	chr17:15732400-15732600	Enhancers	Fetal Lung	lung
21	chr17:15732400-15732600	Enhancers	Fetal Muscle Trunk	muscle
22	chr17:15732400-15732600	Enhancers	Rectal Mucosa Donor 29	rectum
23	chr17:15732400-15732600	Enhancers	Stomach Mucosa	stomach
24	chr17:15732400-15732600	Enhancers	Stomach Smooth Muscle	stomach
25	chr17:15732400-15732600	Enhancers	HUVEC	blood vessel
26	chr17:15732400-15732600	Enhancers	Monocytes-CD14+_RO01746	blood
27	chr17:15732400-15732600	Flanking Active TSS	NH-A	brain
28	chr17:15732400-15732600	Enhancers	NHEK	skin
29	chr17:15732400-15732600	Flanking Active TSS	Osteobl	bone
30	chr17:15732400-15732800	Enhancers	ES-I3 Cell Line	embryonic stem cell
31	chr17:15732400-15732800	Enhancers	Breast Myoepithelial Primary Cells	Breast
32	chr17:15732400-15732800	Enhancers	Fetal Heart	heart
33	chr17:15732400-15732800	Enhancers	A549	lung
34	chr17:15732400-15732800	Enhancers	HepG2	liver
35	chr17:15732600-15732800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
36	chr17:15732600-15733000	Enhancers	NH-A	brain
37	chr17:15732600-15733600	Enhancers	Osteobl	bone
38	chr17:15732600-15733800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
39	chr17:15732600-15734400	Weak transcription	NHEK	skin
40	chr17:15732600-15734800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
41	chr17:15732800-15734200	Weak transcription	A549	lung
42	chr17:15732800-15734600	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
43	chr17:15733000-15733600	Weak transcription	NH-A	brain
44	chr17:15733200-15733600	Enhancers	NHDF-Ad	bronchial
45	chr17:15733200-15735000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
46	chr17:15733400-15734800	Enhancers	GM12878-XiMat	blood
47	chr17:15733600-15733800	Enhancers	NH-A	brain
48	chr17:15733600-15734600	Weak transcription	NHDF-Ad	bronchial
49	chr17:15733600-15737800	Enhancers	Primary monocytes fromperipheralblood	blood
50	chr17:15734200-15734600	Enhancers	Monocytes-CD14+_RO01746	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links